American Association of Individual Investors2d
Why Zentalis Pharmaceuticals, Inc.’s (ZNTL) Stock Is Up 31.29%
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has surged by 31.29%, which has investors questioning if this is right time to sell.
Can a heart failure drug effectively treat a lethal form of ovarian cancer? Scientists hope the answer is 'yes'
Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...
American Association of Individual Investors9d
Why Zentalis Pharmaceuticals, Inc.’s (ZNTL) Stock Is Down 21.25%
Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...
Unlocking new insights into hereditary ovarian cancer risk
Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most ...
The Lancet20d
TACE plus immune checkpoint inhibitor-based systemic therapies for hepatocellular carcinoma
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cancer Research21d
The Landscape of ctDNA in Appendiceal Adenocarcinoma
1Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. *Corresponding Author: John Paul Shen, Department of Colon and Rectal Surgery, The ...
Cancer Research28d
Comparison of Shared Class I HLA-Bound Noncanonical Neoepitopes between Normal and Neoplastic Tissues of Pancreatic Adenocarcinoma
Clin Cancer Res OF1–OF10. Developing T-cell or vaccine therapies for pancreatic ductal adenocarcinoma (PDAC) has been challenging because of a lack of knowledge regarding immunodominant, ...